BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.
BK positive
adult
ok to participed to research
under guardianship
under curatorship
opposed to research
deprived of liberty
\- Adult patient with a posititive serology BK confirmed
Cohort
Retrospective
Not listed
Ability of the isolated monoclonal antibodies to neutralize all 3 BKV genotypes
The neutralization titer will be defined as the dilution of the sample that produced 50% inhibition of pseudovirion infectivity (IC50)
Click on the lead sponsor to view all of their trials.
